|
HS Code |
804616 |
| Product Name | [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate |
| Cas Number | 872365-14-5 |
| Molecular Formula | C13H18BrNO2 |
| Molecular Weight | 300.19 |
| Appearance | White to off-white solid |
| Purity | Typically >98% |
| Melting Point | 44-47°C |
| Smiles | CC(C1=CC=C(C=C1)Br)NC(=O)OC(C)(C)C |
| Inchi | InChI=1S/C13H18BrNO2/c1-9(11-5-7-12(14)8-6-11)15-10(16)17-13(2,3)4/h5-9,15H,1-4H3 |
| Optical Activity | (R)-configuration |
| Storage Temperature | 2-8°C |
| Solubility | Soluble in DMSO, slightly soluble in methanol and ethanol |
As an accredited [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of organic synthesis, and especially chiral chemistry, researchers keep searching for reliable molecules that push the boundaries of what’s possible in medical and material innovation. Countless compounds cycle through labs each year, but [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate draws attention for good reasons. As someone who’s both read the literature and watched these reactions unfold on the bench, it’s clear why this compound keeps popping up in synthesis discussions and protocols.
[(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate brings together a chiral center with a bromoarene scaffold and a tert-butyl carbamate (Boc) protecting group—the chemistry world loves that kind of combination. The core of its appeal lies in the (1R) configuration, giving chemists an efficient entry point for building enantiomerically pure secondary amines, a class that shows up in pharmaceuticals far more often than most people realize. The presence of the 4-bromophenyl group widens its role: this group acts as a flexible handle for cross-coupling techniques, enabling Suzuki and Buchwald-Hartwig reactions that every modern synthetic lab uses to construct complicated targets.
Anyone who’s spent time weighing powders knows the physical feel of this compound—most commercial sources offer it as a white to off-white solid. Its shelf stability owes credit to the Boc group, giving peace of mind during storage and weighing. The unmistakable bromoarene odor stays minimal at room temperature—helpful in labs where air quality matters. In my own experience, the handling straightforwardness of the compound, weighed against glassy or viscous intermediates, stands out: precise weighing, no fastidious drying cycles, just solid material ready for the next reaction.
The heart of the matter is relevance in synthetic chemistry. [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate slots right into the workflow for preparing chiral amines by offering a practical solution for introducing chirality with strong functional group tolerance. Setting out to make enantiopure amines? This molecule makes a solid starting point. I’ve seen graduate students and seasoned industrial chemists both rely on Boc-protected amines like this one for scale-up, because the protecting group stays robust through a range of conditions, then cleaves off cleanly when it’s finally time to reveal the amine.
The bromophenyl position propels versatility. Once you’ve introduced this compound into a reaction sequence, a whole universe of transformations opens up—think palladium-catalyzed coupling to append new aromatics, or radical reactions to replace the bromide with other functional groups. Beyond just practical convenience, this offers a kind of creative freedom; the 4-bromophenyl ring can anchor a range of synthetic pathways without sacrificing optical purity at the chiral carbon. Not every molecule brings that kind of flexibility to the table.
If you look at the recent scientific literature, [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate shows up in routes to active pharmaceutical ingredients, intermediates for agrochemicals, and even specialty materials. Academic groups report step-efficient syntheses where chiral intermediates feed straight into key bond-forming steps, cutting down on protecting group changes and unnecessary redox steps—a trend driven by both cost and sustainability. The molecule’s predictable reactivity and protection profile sit behind these innovations.
Plenty of other Boc-protected chiral amines circulate in chemical catalogs, but not all deliver the same combination of functional group handles and robust protection. For comparison, look at related (1R)-1-phenylethyl tert-butyl carbamate—the lack of a bromine atom locks you out of certain coupling and substitution chemistry. If you’ve ever had a synthetic sequence stall at a stubborn position, you know the value of a bromo-group for cross-coupling to push a route forward, perhaps swapping in a heterocycle or extending conjugation.
Even simple variations in the aromatic ring’s substitution pattern reshape the compound’s story. Moving the bromine from para to ortho or meta, or switching to other halides, changes not only physical handling but how the molecule plays in catalyzed reactions. The para positioning in this compound reduces steric hindrance and keeps oxidative addition steps efficient, while other analogues—though valuable—often require more forcing conditions or tolerate fewer options for subsequent transformations. Real productivity shows up here, especially on the scale-up end where every minute and reagent counts.
Chirality remains at the heart of drug discovery and development. Modern regulatory environments take a hard stance on enantiopure drugs, leaving no room for error in synthetic strategies. Starting from reliable, highly pure intermediates reduces headaches further downstream; even one failed batch, contaminated with a racemic impurity, means lost time and money.
[(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate appeals not only for its chemical utility, but also for its accessibility and straightforward incorporation into scalable processes. Many commercial sources ensure high optical purity and retain batch-to-batch consistency—a must for quality management systems under good manufacturing practices (GMP). In research labs running hundreds of small-scale reactions a week, and production settings pushing kilos through a reactor, this consistency stands as more than a technical detail. It becomes a trust factor between the bench chemist and their raw materials.
I’ve talked to process chemists who’ve fought through endless trouble-shooting sessions, only to realize that inconsistent chiral purity in starting material torpedoed their yield and cost assumptions. Leaning on a compound like this gives room to focus on downstream steps, exploring creative chemistry instead of battling basic reproducibility. It doesn’t hurt that purification steps tend to stay simple, since the Boc group allows for selective deprotection and crystallization, sidestepping awkward chromatography.
Chemists today make choices with an eye toward green chemistry. The minimal waste and high atom economy of transformations built on this carbamate fit with those priorities. Direct uses in cross-coupling reactions, plus resistance to racemization under mild conditions, limit the need for harsh reagents and energy-intensive columns. A generation ago, it was common to see synthetic trees consumed by extra protecting group swaps and lengthy chiral separations. Now, molecules like [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate bring those waste outputs down.
Supporting greener chemistry takes multiple steps: reducing hazardous waste, cutting energy use, and streamlining purifications. In published syntheses, reactions using this compound often display mild conditions and short step counts. Fewer solvents and less energetic input go into each batch, which saves not just cost but aligns with present-day environmental targets. Every step cut from the synthesis shrinks a laboratory’s carbon footprint—a measurable benefit for companies aiming to meet stricter environmental regulations.
From my own experience, switching to intermediates with reliable protection and functional handles like this one reduces unnecessary byproducts, sidestepping problematic secondary reactions. There’s added comfort in knowing that each gram of product produced moves you closer to cleaner water streams and safer reaction spaces.
Chemical reliability depends on more than just molecular structure—it’s also about day-to-day logistics. [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate holds up well in typical storage conditions. Its Boc protection shields the amine, letting the molecule withstand modest shifts in humidity or ambient lab temperature. Direct sunlight or strong acids will, as with most carbamates, eventually trigger deprotection, but I’ve found unopened sample jars stable for over a year on the shelf.
Handlers appreciate this stability, especially on big projects with extended timelines. No one wants to re-run purity checks mid-campaign or toss half-used containers because of degradation. The combination of solid form, high melting point, and chemical inertia keeps waste down and lowers the burden of inventory management. As someone who’s seen rushed reactions ruined by decomposed reagents, the long shelf life of this compound doesn’t just matter—it spares budgets and nerves.
Looking over the last several years of published work, there’s a clear trend toward more efficient, functionally diverse chiral centers. Tools like [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate stand at the forefront, enabling the synthesis of molecules that would have been seen as out of reach only a generation ago.
Medicinal chemistry, always hungry for new ways to lay out carbon, nitrogen, and halogen atoms, seizes on intermediates like this for rapid analog generation. With modern cross-coupling partners, a chemist can run parallel sequences, generating large families of compounds from a common intermediate. This approach dramatically speeds up optimization for biological activity without sacrificing the fine control that makes chiral drugs so effective.
Outside pharma, interest grows in specialty materials—OLEDs, advanced polymers, and sensors—that require precisely placed chiral handles. Tuning electronic properties or solubility often hinges on slight modifications at a core like the one provided by this carbamate. I’ve heard from peers working at the interface of synthetic chemistry and materials science that compounds like these make exploratory work faster and less risky, since well-characterized building blocks remove much of the uncertainty in complex molecule assembly.
No compound is perfect—every tool carries trade-offs. The use of tert-butyl carbamate protection, while sturdy, occasionally holds back reactivity in crowded reaction environments, especially where steric hindrance mounts up. Deprotection conditions, though generally mild, don’t fit every synthetic plan. Some high-sensitivity targets or water-sensitive intermediates suffer from the need to use acids or heating to remove Boc. Creative solutions keep emerging: buffered deprotection techniques, flow-chemistry alternatives, and greener acid sources all push this class of molecules forward.
On the scalability side, the compound’s core synthesis uses standard coupling techniques accessible in most well-equipped facilities. The challenge comes in achieving consistent chiral purity at high throughput. Better asymmetric catalysis, improved resolution steps, and advanced in-line monitoring now help producers supply research and industrial customers with batches that meet strict quality standards without ballooning costs or timelines. I’ve observed this shift first-hand—what once required lengthy manual resolution steps now happens by design, as chiral catalysts and in-process controls take the guesswork out of manufacturing.
It’s worth noting the continual development of new bromo- and haloarene chemistry, expanding the ways these intermediates play a role in molecule construction. As cross-coupling catalysts become cheaper, more active, and less sensitive to trace impurities, options for downstream transformation only grow. While academic groups push the frontier, industrial users feed those breakthroughs back into process improvements, closing a virtuous loop of discovery and application.
Modern research and production environments pay more attention than ever to the transparency and traceability of their chemicals. In the past, it didn’t matter to many chemists where their reagents originated, as long as they performed in reactions. Smart sourcing today means more than that. Every delivery of [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate comes with documentation and purity profiles that satisfy evolving regulatory demands.
The fact that suppliers now support full traceability, from raw material source all the way to the finished vial, puts researchers and manufacturers in a stronger position when it’s time for audits or validation checks. Pharmaceuticals and fine chemical operations rarely get a pass when authorities investigate material flows. Having intermediates that pass scrutiny saves headaches down the line. In my own lab, tight documentation around chiral purity, batch identity, and contaminant screening forms part of every project folder—not just a hoop to jump through, but a real asset in ensuring the quality of final products.
Reflecting on the role of [(1R)-1-(4-Bromophenyl)Ethyl]Tert-Butyl Carbamate, its value rests less in showy novelty and more in practical versatility. Molecules like this don’t show up in news headlines or splashy press releases, but in countless procedure sections, theses, and patents, they quietly drive discovery and deliver reliability where it matters. Researchers, in my experience, favor compounds that blend robust performance with a useful array of transformation options; few things bring more satisfaction than having a well-behaved chiral building block that keeps a project moving forward.
Having worked on both small-scale research and multi-kilo syntheses, I can say that every successful campaign leans on a handful of workhorse intermediates. This carbamate earns its spot by showing up where both creativity and practicality demand. Whether pushing the boundaries of medicinal chemistry or enabling new materials, it serves, not as a scientific curiosity, but as a foundation for innovation. The chemistry community moves forward fastest on the back of reliable molecules—and this compound sets that standard for the next generation.